메뉴 건너뛰기




Volumn 37, Issue 5, 2015, Pages 619-625

Evaluation of target attainment of vancomycin area under the curve in children with methicillin-resistant staphylococcus aureus bacteremia

Author keywords

AUC; Bacteremia; MRSA; Pediatric; Vancomycin

Indexed keywords

GENTAMICIN; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

EID: 84941925534     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000190     Document Type: Article
Times cited : (39)

References (25)
  • 1
    • 79951804452 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
    • Kim DI, Im MS, Choi JH, et al. Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients. Korean J Pediatr. 2010;53:1000-1005.
    • (2010) Korean J Pediatr. , vol.53 , pp. 1000-1005
    • Kim, D.I.1    Im, M.S.2    Choi, J.H.3
  • 2
    • 80052188407 scopus 로고    scopus 로고
    • Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations
    • Frymoyer A, Guglielmo BJ, Wilson SD, et al. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy. 2011;31:871-876.
    • (2011) Pharmacotherapy , vol.31 , pp. 871-876
    • Frymoyer, A.1    Guglielmo, B.J.2    Wilson, S.D.3
  • 3
    • 79951821210 scopus 로고    scopus 로고
    • Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children: Executive summary
    • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52:285-292.
    • (2011) Clin Infect Dis. , vol.52 , pp. 285-292
    • Liu, C.1    Bayer, A.2    Cosgrove, S.E.3
  • 4
    • 70350510606 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    • Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29:1275-1279.
    • (2009) Pharmacotherapy , vol.29 , pp. 1275-1279
    • Rybak, M.J.1    Lomaestro, B.M.2    Rotschafer, J.C.3
  • 5
    • 67649543995 scopus 로고    scopus 로고
    • Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate
    • Frymoyer A, Hersh AL, Benet LZ, et al. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009;28:398-402.
    • (2009) Pediatr Infect Dis J. , vol.28 , pp. 398-402
    • Frymoyer, A.1    Hersh, A.L.2    Benet, L.Z.3
  • 6
    • 77951899851 scopus 로고    scopus 로고
    • Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: A Monte Carlo simulation
    • Frymoyer A, Hersh AL, Coralic Z, et al. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation. Clin Ther. 2010;32:534-542.
    • (2010) Clin Ther. , vol.32 , pp. 534-542
    • Frymoyer, A.1    Hersh, A.L.2    Coralic, Z.3
  • 7
    • 84891836161 scopus 로고    scopus 로고
    • Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections
    • Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. Pediatr Infect Dis J. 2013;32:1077-1079.
    • (2013) Pediatr Infect Dis J. , vol.32 , pp. 1077-1079
    • Frymoyer, A.1    Guglielmo, B.J.2    Hersh, A.L.3
  • 8
    • 84876295339 scopus 로고    scopus 로고
    • Improved vancomycin dosing in children using area under the curve exposure
    • Le J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J. 2013;32:e155-e163.
    • (2013) Pediatr Infect Dis J. , vol.32 , pp. e155-e163
    • Le, J.1    Bradley, J.S.2    Murray, W.3
  • 9
    • 77950208675 scopus 로고    scopus 로고
    • Should higher vancomycin trough levels be targeted for invasive community-acquired methicillinresistant Staphylococcus aureus infections in children?
    • Jimenez-Truque N, Thomsen I, Saye E, et al. Should higher vancomycin trough levels be targeted for invasive community-acquired methicillinresistant Staphylococcus aureus infections in children? Pediatr Infect Dis J. 2010;29:368-370.
    • (2010) Pediatr Infect Dis J. , vol.29 , pp. 368-370
    • Jimenez-Truque, N.1    Thomsen, I.2    Saye, E.3
  • 10
    • 77749255891 scopus 로고    scopus 로고
    • Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin
    • Welsh KJ, Abbott AN, Lewis EM, et al. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin. J Clin Microbiol. 2010;48:894-899.
    • (2010) J Clin Microbiol. , vol.48 , pp. 894-899
    • Welsh, K.J.1    Abbott, A.N.2    Lewis, E.M.3
  • 11
    • 79953907324 scopus 로고    scopus 로고
    • Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: Support for consensus guidelines suggested targets
    • Kullar R, Davis SL, Levine DP, et al. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis. 2011;52:975-981.
    • (2011) Clin Infect Dis. , vol.52 , pp. 975-981
    • Kullar, R.1    Davis, S.L.2    Levine, D.P.3
  • 12
    • 84879585901 scopus 로고    scopus 로고
    • Acute kidney injury during vancomycin therapy in critically ill children
    • Totapally BR, Machado J, Lee H, et al. Acute kidney injury during vancomycin therapy in critically ill children. Pharmacotherapy. 2013;33:598-602.
    • (2013) Pharmacotherapy. , vol.33 , pp. 598-602
    • Totapally, B.R.1    Machado, J.2    Lee, H.3
  • 13
    • 79951579705 scopus 로고    scopus 로고
    • Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children
    • McKamy S, Hernandez E, Jahng M, et al. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr. 2011;158:422-426.
    • (2011) J Pediatr. , vol.158 , pp. 422-426
    • McKamy, S.1    Hernandez, E.2    Jahng, M.3
  • 14
    • 0033958126 scopus 로고    scopus 로고
    • A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population
    • Lamarre P, Lebel D, Ducharme MP. A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population. Antimicrob Agents Chemother. 2000;44:278-282.
    • (2000) Antimicrob Agents Chemother. , vol.44 , pp. 278-282
    • Lamarre, P.1    Lebel, D.2    Ducharme, M.P.3
  • 15
    • 84941895997 scopus 로고    scopus 로고
    • Validation of a pediatric population pharmakokinetic model for vancomycin
    • Nov. 21 Epub ahead of print
    • Hahn A, Frenck RW, Zou Y, et al. Validation of a pediatric population pharmakokinetic model for vancomycin. Ther Drug Monit. 2014 Nov. 21 [Epub ahead of print].
    • (2014) Ther Drug Monit.
    • Hahn, A.1    Frenck, R.W.2    Zou, Y.3
  • 16
    • 84941916894 scopus 로고    scopus 로고
    • Low sensitivity of discharge diagnostic codes for Staphylococcus aureus bloodstream infections at a large pediatric hospital
    • April 29, Boston, MA
    • Kreppel A, Rice M, Back N, et al. Low sensitivity of discharge diagnostic codes for Staphylococcus aureus bloodstream infections at a large pediatric hospital. Presented at the Pediatic Academic Society Meeting; April 29, 2012; Boston, MA.
    • (2012) The Pediatic Academic Society Meeting
    • Kreppel, A.1    Rice, M.2    Back, N.3
  • 17
    • 0026580927 scopus 로고
    • MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring
    • Proost JH, Meijer DK. MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med. 1992;22:155-163.
    • (1992) Comput Biol Med. , vol.22 , pp. 155-163
    • Proost, J.H.1    Meijer, D.K.2
  • 18
    • 0031985373 scopus 로고    scopus 로고
    • Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, Bayesian feedback and individualised target goals
    • Jelliffe RW, Schumitzky A, Bayard D, et al. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, Bayesian feedback and individualised target goals. Clin Pharmacokinet. 1998;34:57-77.
    • (1998) Clin Pharmacokinet. , vol.34 , pp. 57-77
    • Jelliffe, R.W.1    Schumitzky, A.2    Bayard, D.3
  • 19
    • 84888642447 scopus 로고    scopus 로고
    • Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive Staphylococcal infections
    • Chhim RF, Arnold SR, Lee KR. Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive Staphylococcal infections. J Pediatr Infect Dis Soc. 2013;2:259-262.
    • (2013) J Pediatr Infect Dis Soc. , vol.2 , pp. 259-262
    • Chhim, R.F.1    Arnold, S.R.2    Lee, K.R.3
  • 20
    • 84862965924 scopus 로고    scopus 로고
    • Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization
    • Brown J, Brown K, Forrest A. Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization. Antimicrob Agents Chemother. 2012;56:634-638.
    • (2012) Antimicrob Agents Chemother. , vol.56 , pp. 634-638
    • Brown, J.1    Brown, K.2    Forrest, A.3
  • 21
    • 84875183210 scopus 로고    scopus 로고
    • Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia
    • Holmes NE, Turnidge JD, Munckhof WJ, et al. Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2013;57:1654-1663.
    • (2013) Antimicrob Agents Chemother. , vol.57 , pp. 1654-1663
    • Holmes, N.E.1    Turnidge, J.D.2    Munckhof, W.J.3
  • 22
    • 84879435833 scopus 로고    scopus 로고
    • A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis
    • Gawronski KM, Goff DA, Brown J, et al. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Clin Ther. 2013;35:772-779.
    • (2013) Clin Ther. , vol.35 , pp. 772-779
    • Gawronski, K.M.1    Goff, D.A.2    Brown, J.3
  • 23
    • 84872925796 scopus 로고    scopus 로고
    • Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureusassociated septic shock
    • Zelenitsky S, Rubinstein E, Ariano R, et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureusassociated septic shock. Int J Antimicrobi Agents. 2013;41:255-260.
    • (2013) Int J Antimicrobi Agents. , vol.41 , pp. 255-260
    • Zelenitsky, S.1    Rubinstein, E.2    Ariano, R.3
  • 24
    • 0029145482 scopus 로고
    • Influence of malignancy on the pharmacokinetics of vancomycin in infants and children
    • Chang D. Influence of malignancy on the pharmacokinetics of vancomycin in infants and children. Pediatr Infect Dis J. 1995;14:667-673.
    • (1995) Pediatr Infect Dis J. , vol.14 , pp. 667-673
    • Chang, D.1
  • 25
    • 80052895223 scopus 로고    scopus 로고
    • Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: Methodology correlations, temporal trends and clonal patterns
    • van Hal SJ, Barbagiannakos T, Jones M, et al. Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. J Antimicrob Chemother. 2011;66:2284-2287.
    • (2011) J Antimicrob Chemother. , vol.66 , pp. 2284-2287
    • Van Hal, S.J.1    Barbagiannakos, T.2    Jones, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.